Revenue (Quarterly) Chart

View Revenue (Quarterly) for OMCL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Quarterly) Chart
Start Trial

Historical Revenue (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
June 30, 2026 312.21M
March 31, 2026 309.88M
December 31, 2025 313.98M
September 30, 2025 310.63M
June 30, 2025 290.56M
March 31, 2025 269.67M
December 31, 2024 306.88M
September 30, 2024 282.42M
June 30, 2024 276.79M
March 31, 2024 246.15M
December 31, 2023 258.85M
September 30, 2023 298.66M
June 30, 2023 298.97M
March 31, 2023 290.63M
December 31, 2022 297.67M
September 30, 2022 348.06M
June 30, 2022 331.39M
March 31, 2022 318.83M
December 31, 2021 311.03M
September 30, 2021 296.40M
June 30, 2021 272.74M
March 31, 2021 251.84M
December 31, 2020 249.20M
September 30, 2020 213.70M
June 30, 2020 199.62M
Date Value
March 31, 2020 229.69M
December 31, 2019 248.29M
September 30, 2019 228.80M
June 30, 2019 217.41M
March 31, 2019 202.52M
December 31, 2018 211.75M
September 30, 2018 204.27M
June 30, 2018 188.67M
March 31, 2018 182.62M
December 31, 2017 196.37M
September 30, 2017 186.75M
June 30, 2017 181.04M
March 31, 2017 148.55M
December 31, 2016 171.97M
September 30, 2016 176.74M
June 30, 2016 172.91M
March 31, 2016 171.00M
December 31, 2015 130.32M
September 30, 2015 125.23M
June 30, 2015 112.79M
March 31, 2015 116.22M
December 31, 2014 121.54M
September 30, 2014 112.54M
June 30, 2014 105.05M
March 31, 2014 101.76M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
Carlsmed, Inc. 18.94M
Vaso Corp. 11.19M
Global Innovative Platforms, Inc. 0.0507M
TruBridge, Inc. 86.27M
Veradigm, Inc. --